Predicta Biosciences is a precision oncology company integrating cutting edge multiomics and liquid biopsies to develop innovative diagnostic and therapeutic products. Predicta's diagnostic product portfolio removes the burden of bone-marrow biopsies, through small blood-based samples, and enables best-in-class treatment decision-making for immunotherapies. Utilizing the data from the diagnostic platform, Predicta has an in-house therapeutic pipeline of novel immunotherapy targets in pre-clinical discovery and development.

Biotechnology

Health Diagnostics

Life Sciences

Therapeutics

Predicta Biosciences

The Cambridge office focuses on advanced research and development in computational biology and clinical technologies.

People (6)

Jobs (0)

Other offices